Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenazopyridine vs Lidocaine for Pain Control in Bladder Botox Injections
NCT06514430Phase 4Withdrawn
- Sponsor
- Montefiore Medical Center
- Start
- Jul 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenazopyridine in procedural pain, sponsored by Montefiore Medical Center. Planned start Jul 2025; status: withdrawn.
02
Drugs
phenazopyridine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06514430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06514430.